Certificate PL-26-00313 · TB-500 Nasal Spray · lot PL-2610-200
VerifyCertificate page
PrymaLab
PrymaLab
PrymaLab Analytical · In-house laboratory
3705 Music Branch Rd, Ashland, KY 41102 · +1 (606) 465-9063 · prymalab.net
Certificate no.
PL-26-00313
Verification key
C5KNGX6K
Scan or enter both at
prymalab.net/testing/verify
Certificate of Analysis · Lot release

TB-500 Nasal Spray

Lot PL-2610-200 · Solution · Label claim 11 mg per bottle
Tested in-house by PrymaLab
In-house analytical result,
not an independent third-party test
Lot / batch number
PL-2610-200
Date made
2026-10-07
Date of analysis
2026-10-08
Date issued
2026-10-15
Retest / expiry
2028-10-07
Units in lot / sampled
328 / 2
Storage
—
Certificate type
Lot COA, 2 pages
Compound
TB-500
N-acetyl thymosin β4, full-length 43-residue peptide
CAS number
77591-33-4
Molecular formula
C212H350N56O78S
Theoretical mass (avg.)
4,963.44 Da
Sequence
Ac-43-aa Tbeta4
Purity · RP-HPLC, area %
99.44%
Specification ≥ 99.0% • main peak at 14.82 min
Identity · Observed Mass
4,963.42 Da
Theoretical 4,963.44 Da • −0.02 Da (4 ppm)
Overall conclusion
PASS
Meets every specification for the tests performed
TestMethodSpecificationResultConclusion
Identity (mass)LC-MS, ESI positiveTheoretical ± 1.0 Da4,963.42 DaPASS
PurityRP-HPLC, UV 214 nm, area%≥ 99.0%99.44%PASS
Largest impurityRP-HPLC, area%≤ 1.0%0.33% (RT 15.60)PASS
Assay (label claim)Assay vs label claim10.45–11.55 mg/bottle10.77 mg/bottlePASS
Bacterial endotoxinLAL, kinetic≤ 5.0 EU/mg0.305 EU/mgPASS
Aerobic count (TAMC)USP <61>< 10 CFU/mL< 10 CFU/mLPASS
Yeast & mold (TYMC)USP <61>< 10 CFU/mL< 10 CFU/mLPASS
E. coliUSP <62>AbsentAbsentPASS

1HPLC chromatogram

Data file: PL-2610-200-HPLC.raw · Column C18, 150 × 4.6 mm · UV 214 nm
0.01%0.1%1%10%100%121314151617Retention time (min) · stick height = area % (log scale)99.44% · 14.82 min0.13% †0.10% †0.33% †
Peak plot drawn from the integrated peak table (area %, log scale); it is not the instrument trace, which is retained in PL-2610-200-HPLC.raw. † Nominal reference retention time for the assigned impurity; the main-peak RT is observed in this lot.
PrymaLab
PrymaLab
Certificate of Analysis · continued
TB-500 Nasal Spray · Lot PL-2610-200 · Certificate PL-26-00313
Lot PL-2610-200
Method, peak table and approval

2HPLC method · PL-2610-200-HPLC.raw

Instrument
Waters Alliance e2695
Data System
Empower 3
Detector
UV absorbance
Detection Wavelength
214 nm
Column
C18, 150 × 4.6 mm, 3.5 µm
Mobile Phase A
0.1% TFA in water
Mobile Phase B
0.1% TFA in MeCN
Gradient
5–95% B over 25 min (linear)
Flow Rate
1.0 mL/min
Column Temperature
40 °C
Injection Volume
10 µL

3Gradient program

Time (min)% A% B
0.0955
25.0595

4Peak table

PeakRT (min)AreaArea %
113.20 †—0.13
213.90 †—0.10
314.82—99.44
415.60 †—0.33
Total—100.00
Peaks: 1 deamidation product; 2 isoaspartate (isoasp) variant; 3 main peak (TB-500); 4 truncated sequence · Area % from the integrated peak table (absolute areas are not part of the lot-release export) · † nominal reference RT for the assigned impurity · Purity = main peak area ÷ total integrated area × 100, to two decimals; main peak shaded.

5Identity by mass spectrometry

Instrument
Waters SQD
Ionization / Mode
ESI, positive
Reference m/z (charge)
1241.87 (4+) · 993.70 (5+)
Deconvoluted Mass
4,963.42 Da
Theoretical Mass
4,963.44 Da
Difference
−0.02 Da (4 ppm)
Data File
PL-2610-200-MS.d
Acceptance
Within ± 1.0 Da

6Additional tests

TestPerformed byDateReport / file
Assay vs label claimPrymaLab Analytical2026-10-08—
Endotoxin (LAL, kinetic)PrymaLab Analytical2026-10-08—
Microbial limits (USP <61>/<62>)PrymaLab Analytical2026-10-14—
A test with no row here was not performed on this lot. Outside-laboratory reports, when used, are attached and named below.

7Review and approval

D. Reynolds
Analyst · performed the testing
Date: 2026-10-15
S. Calloway
Reviewer · checked against raw data
Date: 2026-10-15
M. Phelps
Lab Director · approved for release
Date: 2026-10-15